Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CDB-2914 vs Levonorgestrel for Emergency Contraception
NCT00551616Phase 3Completed
- Sponsor
- HRA Pharma
- Start
- Apr 2007
- Primary completion
- Apr 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 3, randomised, single-blind trial of ulipristal in pregnancy (2 arms), sponsored by HRA Pharma. Primary endpoint: Number of Participants With Pregnancy Within 72 hours of Unprotected Intercourse. Started Apr 2007; status: completed.
02
Drugs
ulipristal
03
Conditions
pregnancy
Beyond the preview
Go deeper on NCT00551616.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00551616.